TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

80.80$ +1.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

GRAIL, LLC (GRAL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 147 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GRAL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
0.0 15 56 93 126 147
14 10 115 172 189 204 210
-14 -10 -100 -116 -96 -78 -63
223 167 193 460 330 339 322 196
58 81 110 181 174 200 214 159
287 256 316 1,165 5,326 1,420 2,111 472
-287 -256 -316 -1,265 -5,443 -1,515 -2,189 -534
-275 -245 -312 -1,265 -5,441 -1,508 -2,162 -535
0.5 -0.2 0.0 -17 -42 -42 -135 -126
-276 -245 -312 -1,248 -5,399 -1,466 -2,027 -408
-269 -243 -309 -1,207 -588 -638 -610 -378

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?